entertainment -WSS

entertainment

author：comprehensive 2025-09-05 06:07:09 - browse：511

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： STAT Summit: GSK CEO on pharma giant's new direction

WSS

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

NIH confirmation hearing shows politicization of research

Impact of Dobbs ruling felt at reproductive medicine meeting

Researchers explore possible ties between long Covid, menopause

Princess Kate attends Wimbledon with Roger Federer: See the photos

STAT Readout Newsletter: Today's biggest biotech updates

explore

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

How one medical school became remarkably diverse

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

As demand for Covid shots wanes, Moderna seeks its next success

2023 STAT Wunderkinds: get to know the winners

Malaria cases in Florida and Texas: Here’s what you need to know

The explosion of genetic testing requires a new approach

Moonlake's readout produced a cash windfall. Risks remain

Adele warns fans about throwing things at performers onstage

Apple is now the first public company to be valued at $3 trillion

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

hotspot

Israel withdraws forces after 2

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

First Opinion Podcast: Long Covid needs a new approach

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

FDA struggles to regulate food additives, sometimes for decades

focus

knowledge

Wikipedia

Wikipedia